Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Ford closes out August with the cautious signals flagged last week now further entrenched — short interest has continued to build and options traders remain more hedged than at any point in the prior year. The options…
Fiserv enters September under a double pressure — shorts have rebuilt at speed while the stock slides to its lowest levels of the year, and the Street offers little relief, clustered around hold-equivalent ratings with…
ExxonMobil has reversed the week-ago selloff in full, with the stock gaining 2.4% this week to close at $164.55 — clawing back almost exactly what the prior note flagged as lost ground and putting the stock back within…
Ovintiv heads into September with short sellers cutting exposure at a meaningful pace, while the Street's most active voice on the name just nudged its target higher — a combination that frames the week's modest rally…
Edison International clawed back 8.9% on September 1 to close at $58.80 — a relief rally after one of the most violent single-session collapses in the stock's modern history, yet one that leaves it still down 21% on…
Eaton Corporation has now shed nearly 6% over the past month, extending the retreat from its post-earnings peak even as the analyst community remains firmly in its corner. The gap between price and conviction is stark.…
DIS enters September with an awkward split personality: a stock that rallied more than 10% in August yet gave back nearly 5% in the final week, landing at $106.22 with the Street still pointing to materially higher…
DAKT heads into September with short sellers quietly unwinding positions and an activist investor visibly reducing its bet — two forces pulling in the same direction, leaving the stock's next move more dependent on…
Curtiss-Wright has dropped 20% in a month to $577.99, yet the short-selling apparatus around it remains almost entirely inert — that disconnect is the most interesting thing about the stock right now. The price action…
Cullen/Frost Bankers heads into September with a telling disconnect: short sellers are cutting positions at their fastest pace in months, yet the stock has still dropped 3% on the week to $158.32 — leaving bulls…
Citigroup heads into the new week with some of August's sharpest bearish signals softening at the edges — but the overall posture still leans cautious. Yesterday's note flagged the put-call ratio hitting a 52-week high…
CHDN heads into September with an eye-catching divergence: a fresh analyst initiation sets a bullish tone, while options positioning has swung to its most put-heavy level of the past year. The options story is the…
Chevron closed Tuesday at $211.05, up 5.6% on the week — the support band that dominated two prior notes has now been cleared decisively, and the options market has rotated from defensive to neutral in tandem. The most…
Caterpillar enters September with its CEO selling shares at the market and the stock down 4% on the week — a combination that puts the near-term bull case under mild pressure even as the fundamental story remains…
Carnival Corporation enters its September 25 earnings with the stock in freefall and options markets registering the most defensive posture of the past year. The price tells the story first. CCL shed 11.1% on the week…
CVS Health enters September on the front foot — up 5% on the week and 3.9% on Tuesday alone — yet options positioning tells a more guarded story, and the gap between price recovery and a still-challenged earnings…
CTS Corporation enters September having shed 12% over the past month, yet the week's most actionable development is a fresh analyst initiation that puts a $67 price target on the table — nearly 20% above where the…
Materion Corporation heads into September with fresh analyst conviction arriving just as short sellers make a decisive exit — a combination that puts the specialty materials name in an interesting spot after a…
BF.B enters September with its most significant short interest unwind in months, even as the stock itself continues to slide — a divergence that makes this week's setup worth unpacking. The clearest development is the…
Bristol-Myers Squibb enters September with the most interesting tension sitting on the Street rather than in the lending market — a wave of target-price upgrades following Q2 earnings that left the consensus more…
